社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Cerevel Therapeutics Holdings, Inc.(CERE)
44.96
+0.00
0.00%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
Cerevel Therapeutics Holdings, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.cerevel.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Cerevel Therapeutics Holdings, Inc.是特拉华州的一家公司。该公司是一家临床阶段的生物制药公司，将对疾病相关生物学和大脑神经回路的深刻理解与先进的化学和中枢神经系统（中枢神经系统）靶向受体选择性药理学相结合，以发现和设计新的疗法。
2024-08-05
超过5%披露
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024-08-05
超过5%披露
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024-08-01
员工持股计划
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024-08-01
交易所摘牌声明
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024-08-01
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2024-08-01
员工持股计划
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024-08-01
员工持股计划
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024-07-01
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2024-06-04
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2024-05-10
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2024-05-08
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024-04-26
[修订]年度报告
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024-04-02
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2024-03-05
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2024-03-01
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
分时
5日
日
周
月
数据加载中...
最高
44.96
今开
44.96
量比
0.00
最低
44.96
昨收
44.96
换手率
0.00%
热议股票
{"pagemeta":{"title":"Cerevel Therapeutics Holdings, Inc.(CERE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cerevel Therapeutics Holdings, Inc.(CERE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cerevel Therapeutics Holdings, Inc.,CERE,Cerevel Therapeutics Holdings, Inc.股票,Cerevel Therapeutics Holdings, Inc.股票老虎,Cerevel Therapeutics Holdings, Inc.股票老虎国际,Cerevel Therapeutics Holdings, Inc.行情,Cerevel Therapeutics Holdings, Inc.股票行情,Cerevel Therapeutics Holdings, Inc.股价,Cerevel Therapeutics Holdings, Inc.股市,Cerevel Therapeutics Holdings, Inc.股票价格,Cerevel Therapeutics Holdings, Inc.股票交易,Cerevel Therapeutics Holdings, Inc.股票购买,Cerevel Therapeutics Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cerevel Therapeutics Holdings, Inc.(CERE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cerevel Therapeutics Holdings, Inc.(CERE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"CERE","data":{"stockData":{"symbol":"CERE","market":"US","secType":"STK","nameCN":"Cerevel Therapeutics Holdings, Inc.","latestPrice":44.96,"timestamp":1722456000000,"preClose":44.96,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":77824202,"shares":182194722,"eps":-2.736044,"marketStatus":"停牌","change":0,"latestTime":"07-31 16:00:00 EDT","open":44.96,"high":44.96,"low":44.96,"amount":678996554.61312,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.736044,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768467600000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":44.96,"volumeRatio":0},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"18453283","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312524193966-CERE","pdf_url":"","pub_time":1722830400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","symbol":"CERE","title":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524193966/0001193125-24-193966-index.htm","us_notice_code":"Form SC 13D/A","us_title_en":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13D/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524193966/d298988dsc13da.htm","primary":true,"translateUrl":"","linkName":"d298988dsc13da.htm","type":"SC 13D/A","id":"NTFILEBNrWnrfSJew1thLZ","market":"us","size":28569}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-08-05 12:00","pubTimestamp":1722830400,"title_zh":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18452246","market":"us","labels":[],"media":"sec.gov","original_id":"AN7800324000168-CERE","pdf_url":"","pub_time":1722830400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","symbol":"CERE","title":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1805387/000007800324000168/0000078003-24-000168-index.htm","us_notice_code":"Form SC 13D/A","us_title_en":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13D/A CEREVEL THERAPEUTICS HOLDINGS 5","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/78003/000007800324000168/sch13acere8124.htm","primary":true,"translateUrl":"","linkName":"sch13acere8124.htm","type":"SC 13D/A","id":"NTFILE8GUXyamGNCsDepKm","market":"us","size":81469}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2024-08-05 12:00","pubTimestamp":1722830400,"title_zh":"Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18457536","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312524190829-CERE","pdf_url":"","pub_time":1722484800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","symbol":"CERE","title":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524190829/0001193125-24-190829-index.htm","us_notice_code":"Form S-8 POS","us_title_en":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8 POS","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524190829/d877583ds8pos.htm","primary":true,"translateUrl":"","linkName":"d877583ds8pos.htm","type":"S-8 POS","id":"NTFILECLkDeLzgtmAvqqvn","market":"us","size":21099}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2024-08-01 12:00","pubTimestamp":1722484800,"title_zh":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18457325","market":"us","labels":[],"media":"sec.gov","original_id":"AN135445724000549-CERE","pdf_url":"","pub_time":1722484800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","symbol":"CERE","title":"Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","titleType":"交易所摘牌声明","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1805387/000135445724000549/0001354457-24-000549-index.htm","us_notice_code":"Form 25-NSE","us_title_en":"Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1354457/000135445724000549/xslF25X02/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"25-NSE","id":"NTFILEBWvUP7WvFGb31sNq","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Delisting","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"交易所摘牌声明","pubTime":"2024-08-01 12:00","pubTimestamp":1722484800,"title_zh":"Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18457281","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312524190764-CERE","pdf_url":"","pub_time":1722484800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"CERE","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/0001193125-24-190764-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.01: Completion of Acquisition or Disposition of Assets;\nItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;\nItem 3.03: Material Modifications to Rights of Security Holders;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-3.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/d814318dex31.htm","primary":true,"translateUrl":"","linkName":"d814318dex31.htm","type":"EX-3.1","id":"NTFILEFAhCfKk9dszZdL7i","market":"us","size":8235},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/d814318d8k.htm","primary":false,"translateUrl":"","linkName":"d814318d8k.htm","type":"8-K","id":"NTFILEBmBbFQbT6T7RXAqa","market":"us","size":47991},{"description":"EX-3.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/d814318dex32.htm","primary":false,"translateUrl":"","linkName":"d814318dex32.htm","type":"EX-3.2","id":"NTFILEnnX49gN1fB5EbijQ","market":"us","size":82423},{"description":"EX-4.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/d814318dex41.htm","primary":false,"translateUrl":"","linkName":"d814318dex41.htm","type":"EX-4.1","id":"NTFILED44W6ebzHATmGQUo","market":"us","size":21742},{"description":"EX-99.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/d814318dex991.htm","primary":false,"translateUrl":"","linkName":"d814318dex991.htm","type":"EX-99.1","id":"NTFILEdQSFUzo9XfkgSKZB","market":"us","size":19406},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524190764/g814318g0801015501013.jpg","primary":false,"translateUrl":"","linkName":"g814318g0801015501013.jpg","type":"GRAPHIC","id":"NTFILEFgR7vZB6suYhGRxt","market":"us","size":1881}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2024-08-01 12:00","pubTimestamp":1722484800,"title_zh":"Form 8-K - Current report","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18456839","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312524190828-CERE","pdf_url":"","pub_time":1722484800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","symbol":"CERE","title":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524190828/0001193125-24-190828-index.htm","us_notice_code":"Form S-8 POS","us_title_en":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8 POS","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524190828/d877583ds8pos.htm","primary":true,"translateUrl":"","linkName":"d877583ds8pos.htm","type":"S-8 POS","id":"NTFILE5iZQWnYdCHEpNz5C","market":"us","size":21099}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2024-08-01 12:00","pubTimestamp":1722484800,"title_zh":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18456808","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312524190830-CERE","pdf_url":"","pub_time":1722484800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","symbol":"CERE","title":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524190830/0001193125-24-190830-index.htm","us_notice_code":"Form S-8 POS","us_title_en":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8 POS","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000119312524190830/d877583ds8pos.htm","primary":true,"translateUrl":"","linkName":"d877583ds8pos.htm","type":"S-8 POS","id":"NTFILE64diyh8La7AXvxmY","market":"us","size":21099}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2024-08-01 12:00","pubTimestamp":1722484800,"title_zh":"Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18330366","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004724005161-CERE","pdf_url":"","pub_time":1719806400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"CERE","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1805387/000195004724005161/0001950047-24-005161-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1197018/000195004724005161/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE3RSJgUknfpSVXRLK","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2024-07-01 12:00","pubTimestamp":1719806400,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18228029","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004724004366-CERE","pdf_url":"","pub_time":1717448331000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"CERE","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1805387/0001950047-24-004366-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1197018/000195004724004366/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE2eXV23qDDto1Bekh","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2024-06-04 04:58","pubTimestamp":1717448331,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18129439","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004724003567-CERE","pdf_url":"","pub_time":1715313600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"CERE","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1805387/000195004724003567/0001950047-24-003567-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1197018/000195004724003567/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEC5g2ycsfcVPuDCiw","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2024-05-10 12:00","pubTimestamp":1715313600,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18116222","market":"us","labels":[],"media":"sec.gov","original_id":"AN95017024055701-CERE","pdf_url":"","pub_time":1715140800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"CERE","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024055701/0000950170-24-055701-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024055701/cere-20240331.htm","primary":true,"translateUrl":"","linkName":"cere-20240331.htm","type":"10-Q","id":"NTFILEFyjCy7R9JwUSaiMK","market":"us","size":2365750},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024055701/cere-ex31_1.htm","primary":false,"translateUrl":"","linkName":"cere-ex31_1.htm","type":"EX-31.1","id":"NTFILEJ7f4X3GdQwSPMNGe","market":"us","size":14480},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024055701/cere-ex31_2.htm","primary":false,"translateUrl":"","linkName":"cere-ex31_2.htm","type":"EX-31.2","id":"NTFILE94F85X5TkT7wBNvm","market":"us","size":14475},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024055701/cere-ex32_1.htm","primary":false,"translateUrl":"","linkName":"cere-ex32_1.htm","type":"EX-32.1","id":"NTFILEE54MP1BrnUFwZhnH","market":"us","size":7877},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024055701/cere-ex32_2.htm","primary":false,"translateUrl":"","linkName":"cere-ex32_2.htm","type":"EX-32.2","id":"NTFILEFzHjrpP4zMCCZbB6","market":"us","size":7884},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024055701/img33951065_0.jpg","primary":false,"translateUrl":"","linkName":"img33951065_0.jpg","type":"GRAPHIC","id":"NTFILE4cWrhRiDwuD948nM","market":"us","size":118846}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2024-05-08 12:00","pubTimestamp":1715140800,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18037455","market":"us","labels":[],"media":"sec.gov","original_id":"AN95017024049069-CERE","pdf_url":"","pub_time":1714104000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","symbol":"CERE","title":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","titleType":"[修订]年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/0000950170-24-049069-index.htm","us_notice_code":"Form 10-K/A","us_title_en":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"10-K/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/cere-20231231.htm","primary":true,"translateUrl":"","linkName":"cere-20231231.htm","type":"10-K/A","id":"NTFILEEAeACxvWxXatB4qq","market":"us","size":1920299},{"description":"EX-31.3","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/cere-ex31_3.htm","primary":false,"translateUrl":"","linkName":"cere-ex31_3.htm","type":"EX-31.3","id":"NTFILE4o3LvPXBiYZQkFDm","market":"us","size":8233},{"description":"EX-31.4","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/cere-ex31_4.htm","primary":false,"translateUrl":"","linkName":"cere-ex31_4.htm","type":"EX-31.4","id":"NTFILE4zUftNXTum4JMw7B","market":"us","size":8344},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/img33056374_0.jpg","primary":false,"translateUrl":"","linkName":"img33056374_0.jpg","type":"GRAPHIC","id":"NTFILE2Vm4ZCvD1xs4fthT","market":"us","size":2313},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/img33056374_1.jpg","primary":false,"translateUrl":"","linkName":"img33056374_1.jpg","type":"GRAPHIC","id":"NTFILEAfEwiT4bvRjECJZH","market":"us","size":2818},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/img33056374_2.jpg","primary":false,"translateUrl":"","linkName":"img33056374_2.jpg","type":"GRAPHIC","id":"NTFILE4roCTT2WcB1kpjtm","market":"us","size":22487},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/img33056374_3.jpg","primary":false,"translateUrl":"","linkName":"img33056374_3.jpg","type":"GRAPHIC","id":"NTFILE79Pj4YvebFh7LCUy","market":"us","size":22390},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/img33056374_4.jpg","primary":false,"translateUrl":"","linkName":"img33056374_4.jpg","type":"GRAPHIC","id":"NTFILE851VfhcLDoEa1WxV","market":"us","size":1669},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/img33056374_5.jpg","primary":false,"translateUrl":"","linkName":"img33056374_5.jpg","type":"GRAPHIC","id":"NTFILEHZUhRqr7yyVaZu54","market":"us","size":23156},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/img33056374_6.jpg","primary":false,"translateUrl":"","linkName":"img33056374_6.jpg","type":"GRAPHIC","id":"NTFILEEv7K7WfeYPEf2Nsy","market":"us","size":22831},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/img33056374_7.jpg","primary":false,"translateUrl":"","linkName":"img33056374_7.jpg","type":"GRAPHIC","id":"NTFILEEoTA7J8orayyHYgn","market":"us","size":22936},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/img33056374_8.jpg","primary":false,"translateUrl":"","linkName":"img33056374_8.jpg","type":"GRAPHIC","id":"NTFILE6KB4Zf6obKerFgxm","market":"us","size":20742},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/img33056374_9.jpg","primary":false,"translateUrl":"","linkName":"img33056374_9.jpg","type":"GRAPHIC","id":"NTFILEJ82U6yyqq2sKNXH2","market":"us","size":16741},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/img33056374_10.jpg","primary":false,"translateUrl":"","linkName":"img33056374_10.jpg","type":"GRAPHIC","id":"NTFILEEhjqHBfHzR4EF5zz","market":"us","size":3597043},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1805387/000095017024049069/img33056374_11.jpg","primary":false,"translateUrl":"","linkName":"img33056374_11.jpg","type":"GRAPHIC","id":"NTFILEGuJ1UayYsfYtH7dC","market":"us","size":3501}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"[Rev.]Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"[修订]年度报告","pubTime":"2024-04-26 12:00","pubTimestamp":1714104000,"title_zh":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17805805","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004724002798-CERE","pdf_url":"","pub_time":1712003503000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"CERE","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1805387/0001950047-24-002798-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1197018/000195004724002798/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE6quxf5DYptkQvFkK","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2024-04-02 04:31","pubTimestamp":1712003503,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17667844","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004724001800-CERE","pdf_url":"","pub_time":1709591818000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"CERE","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1805387/0001950047-24-001800-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1197018/000195004724001800/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE54cur5JL9GBm1Sme","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2024-03-05 06:36","pubTimestamp":1709591818,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"17653862","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004724001555-CERE","pdf_url":"","pub_time":1709241590000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"CERE","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1805387/0001950047-24-001555-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":null,"gpt_en_title":null,"attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1197018/000195004724001555/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE8tCPqzJuMUushKuz","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2024-03-01 05:19","pubTimestamp":1709241590,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.cerevel.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.1933},{"period":"ytd","weight":0.0174}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cerevel Therapeutics Holdings, Inc.是特拉华州的一家公司。该公司是一家临床阶段的生物制药公司，将对疾病相关生物学和大脑神经回路的深刻理解与先进的化学和中枢神经系统（中枢神经系统）靶向受体选择性药理学相结合，以发现和设计新的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.087399},{"month":2,"riseRate":0.5,"avgChangeRate":-0.01137},{"month":3,"riseRate":0.5,"avgChangeRate":0.043276},{"month":4,"riseRate":0.75,"avgChangeRate":0.024279},{"month":5,"riseRate":0.25,"avgChangeRate":-0.03235},{"month":6,"riseRate":0.75,"avgChangeRate":0.235861},{"month":7,"riseRate":0.25,"avgChangeRate":0.004466},{"month":8,"riseRate":0.4,"avgChangeRate":0.022596},{"month":9,"riseRate":0,"avgChangeRate":-0.047536},{"month":10,"riseRate":0.5,"avgChangeRate":0.109092},{"month":11,"riseRate":0.75,"avgChangeRate":0.067582},{"month":12,"riseRate":1,"avgChangeRate":0.234479}],"exchange":"NASDAQ","name":"Cerevel Therapeutics Holdings, Inc.","nameEN":"Cerevel Therapeutics Holdings, Inc."},"aProfile":null}}}